Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2)

被引:554
|
作者
Valinluck, V
Tsai, HH
Rogstad, DK
Burdzy, A
Bird, A
Sowers, LC [1 ]
机构
[1] Loma Linda Univ, Sch Med, Dept Biochem & Microbiol, Loma Linda, CA 92350 USA
[2] Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland
关键词
D O I
10.1093/nar/gkh739
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytosine methylation in CpG dinucleotides is believed to be important in gene regulation, and is generally associated with reduced levels of transcription. Methylation-mediated gene silencing involves a series of DNA-protein and protein-protein interactions that begins with the binding of methyl-CpG binding proteins (MBPs) followed by the recruitment of histone-modifying enzymes that together promote chromatin condensation and inactivation. It is widely known that alterations in methylation patterns, and associated gene activities, are often found in human tumors. However, the mechanisms by which methylation patterns are altered are not currently understood. In this paper, we investigate the impact of oxidative damage to a methyl-CpG site on MBP binding by the selective placement of 8-oxoguanine (8-oxoG) and 5-hydroxymethylcytosine (HmC) in a MBP recognition sequence. Duplexes containing these specific modifications were assayed for binding to the methyl-CpG binding domain (MBD) of one member of the MBP family, methyl-CpG binding protein 2 (MeCP2). Our results reveal that oxidation of either a single guanine to 8-oxoG or of a single 5mC to HmC, significantly inhibits binding of the MBD to the oligonucleotide duplex, reducing the binding affinity by at least an order of magnitude. Oxidative damage to DNA could therefore result in heritable, epigenetic changes in chromatin organization.
引用
收藏
页码:4100 / 4108
页数:9
相关论文
共 50 条
  • [1] DNA recognition by the methyl-CpG binding domain of MeCP2
    Free, A
    Wakefield, RID
    Smith, BO
    Dryden, DTF
    Barlow, PN
    Bird, AP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (05) : 3353 - 3360
  • [2] MeCP2 and other methyl-CpG binding proteins
    Jorgensen, HF
    Bird, A
    [J]. MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2002, 8 (02): : 87 - 93
  • [3] Biological function of the methyl-CpG binding protein MeCP2
    Bird, A
    Guy, J
    Hendrich, B
    Free, A
    Ng, HH
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 : S15 - S15
  • [4] DISSECTION OF THE METHYL-CPG BINDING DOMAIN FROM THE CHROMOSOMAL PROTEIN MECP2
    NAN, XS
    MEEHAN, RR
    BIRD, A
    [J]. NUCLEIC ACIDS RESEARCH, 1993, 21 (21) : 4886 - 4892
  • [5] Methyl-CpG binding domain (MBD) proteins in Arabidopsis
    Ito, M
    Koike, A
    Yamaguchi, Y
    Koizumi, N
    Sano, H
    [J]. PLANT AND CELL PHYSIOLOGY, 2002, 43 : S147 - S147
  • [6] Binding Analysis of Methyl-CpG Binding Domain of MeCP2 and Rett Syndrome Mutations
    Yang, Ye
    Kucukkal, Tugba G.
    Li, Jing
    Alexov, Emil
    Cao, Weiguo
    [J]. ACS CHEMICAL BIOLOGY, 2016, 11 (10) : 2706 - 2715
  • [7] Structural Basis of the Versatile DNA Recognition Ability of the Methyl-CpG Binding Domain of Methyl-CpG Binding Domain Protein 4
    Otani, Junji
    Arita, Kyohei
    Kato, Tsuyoshi
    Kinoshita, Mariko
    Kimura, Hironobu
    Suetake, Isao
    Tajima, Shoji
    Ariyoshi, Mariko
    Shirakawa, Masahiro
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (09) : 6351 - 6362
  • [8] The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse
    Tate, P
    Skarnes, W
    Bird, A
    [J]. NATURE GENETICS, 1996, 12 (02) : 205 - 208
  • [9] Emerging chromatin structural roles of the methyl-CpG binding protein MeCP2
    Imaizumi, Yui
    Feil, Robert
    [J]. EPIGENOMICS, 2021, 13 (06) : 405 - 410
  • [10] MeCP2 binding to DNA depends upon hydration at methyl-CpG
    Ho, Kok Lian
    McNae, Lain W.
    Schmiedeberg, Lars
    Klose, Robert J.
    Bird, Adrian P.
    Walkinshaw, Malcolm D.
    [J]. MOLECULAR CELL, 2008, 29 (04) : 525 - 531